DONATE NOW:Urgent Call for Healthy Donors as Blood Supply Drops to Dangerously Low LevelsSchedule Appointment

COVID-19 Disease Research

New York Blood Center Enterprises (NYBCe) and its research division, Lindsley F. Kimball Research Institute, are currently engaged on multiple fronts with COVID-19 disease research. We have several research projects already ongoing, such as preclinical trials for a vaccine, and projects in development. Ongoing and planned projects include:

  • Vaccine trials
  • Convalescent plasma collection, distribution, and study
  • COVID-19 therapeutic agents
  • Biomarker screening
  • Antibody testing
  • SARS-CoV-2 inhibitors
  • Clinical research with COVID-19 patients to understand the disease and its relationship with the immune system

To learn more about NYBCe’s current COVID-19 research projects, download this summary.

Interested in forming a research collaboration with NYBCe investigators or procuring samples for your independent study?  Please fill out the Research Inquiry Form below:

Research Inquiry From

 

 


Help Us Fight COVID-19

NYBCe is engaged in various research projects focused on COVID-19 all operating as quickly as possible. We are grateful for any and all support you can give to help our researchers maintain unprecedented speeds and quantities of data collection. If you would like to make a financial contribution, please visit our donation page and select “COVID-19 General Fund” for your “designation”. If you are not able to make a financial donation, please spread the word! Any amount and shout-out makes a difference. 

MAKE A FINANCIAL GIFT TO HELP OUR FIGHT AGAINST COVID-19 Your financial support helps us provide critical healthcare services to our communities during this pandemic, from maintaining an adequate blood supply, to collecting, testing and distributing convalescent plasma to hospitals with the hope that plasma transfusions will help save the lives of COVID-19 patients in critical need.  NYBCe seeks financial support to help advance our efforts in CP patient availability, antibody testing, and in the development of a SARS-CoV-2 vaccine which is currently in the preclinical phase. Your contribution could make all the difference. Together we will win this fight.